-
2025-521950-41-00
5
severe uncontrolled asthma
-
2025-522542-40-00
5
Acute Ischemic Stroke
-
2025-522791-92-00
5
Neoplasm Metastasis
-
2025-522854-37-00
5
Prevention of a Major infection in patients with Hypogammaglobulinemia
-
2025-523117-28-00
4
Relapsed or Refractory Multiple Myeloma
-
2025-523227-22-00
5
Ocular Hypertension
-
2025-523259-72-00
5
Hidradenitis Suppurativa (HS)
-
2025-523461-17-01
5
LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
-
2025-523544-12-00
5
Myelodysplastic neoplasms/syndromes (MDS)
-
2025-523576-23-00
5
Unresectable Stage III non-small cell lung cancer without progression
-
2025-524200-29-00
4
Hospital-acquired bacterial pneumonia or ventilated-associated bacteri
-
2025-524316-11-00
5
Primary Progressive Multiple Sclerosis (PPMS)
-
2025-525006-37-00
5
Infection and sepsis
-
2025-525013-23-00
4
Stage 4 (IV) Non-Small Cell Lung Cancer (NSCLC)
-
2026-525291-26-00
5
Helicobacter Pylori Infection
-
2025-522007-18-00
5
2026-05-27
Relapsed or Refractory Multiple Myeloma
-
2025-524001-33-00
4
2026-05-22
Graves’ Disease
-
2024-519870-38-00
5
2026-05-11
Atherosclerotic cardiovascular disease (ASCVD)
-
2023-508047-40-00
5
2026-04-30
Ovarian cancer
-
2025-520466-22-00
5
2026-04-29
Advanced Platinum-resistant Epithelial Ovarian Cancer
-
2024-511593-70-00
5
2026-04-27
Polyarticular-course juvenile idiopathic arthritis
-
2025-521314-25-00
5
2026-03-19
NPM1-m and KMT2A-r Acute Myeloid Leukemia
-
2025-520467-40-00
9
2026-03-16
High-risk non-muscle invasive bladder cancer (NMIBC) with carcinoma in
-
2025-522492-28-00
4
2026-03-13
AChR-Ab Seropositive Generalized Myasthenia Gravis, Myasthenia Gravis,